IFNAR2 and COVID-19: In COVID-19 patients who also had type 2 diabetes, our results indicated that patients carrying the minor variants of LZTFL1 and RAVER1 (and probably also IFNAR2 and MUC5B) are more likely to have hospitalization-requiring COVID-19 than the general population.